Mutant IDH1-IN-2 |
カタログ番号GC32966 |
変異 IDH1-IN-2 は変異イソクエン酸デヒドロゲナーゼ (IDH) タンパク質の阻害剤であり、LS-MS 生化学アッセイでの IC50、蛍光生化学アッセイでの IC50 は 16.6 nM です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1429176-69-1
Sample solution is provided at 25 µL, 10mM.
Mutant IDH1-IN-2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of in LS-MS biochemical assay, IC50 of 16.6 nM in Fluorescence biochemical assay.Target: Mutant IDH1Mutant IDH1-IN-2 has a neomorphic activity and in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer. More bioactivity information in Patent WO 2013046136A1 (Example 224).
[1]. Huangshu, et al. 3-Pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH and their preparation
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *